Ciprofloxacin PCD Pharma Franchise Company

Cafoli Lifecare offers a Ciprofloxacin range of 11 formulations across tablets, eye drops, eye/ear drops, cream and IV infusion, manufactured in WHO-GMP certified facilities. Distributors building a broad antibiotic portfolio can secure district-wise monopoly franchise rights on this versatile fluoroquinolone.

What is Ciprofloxacin?

Ciprofloxacin is a broad-spectrum second-generation fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, blocking DNA replication in Gram-negative and many Gram-positive organisms. It is listed on the WHO Model List of Essential Medicines. More information is on MedlinePlus.

Therapeutic Applications

Ciprofloxacin is used for urinary tract infections, respiratory and GI infections, typhoid, bone and soft tissue infections, and topically for eye and ear infections. Prescribers span general physicians, urologists, ophthalmologists, ENT specialists, gastroenterologists and surgeons, with infusion serving inpatient care.

Why Ciprofloxacin is a High-Potential Molecule for Distributors

Few antibiotics match ciprofloxacin's breadth of dosage forms — oral, ophthalmic, otic, topical and injectable from one molecule. This lets a franchise partner serve retail pharmacies, eye and ENT clinics and hospitals simultaneously, deepening SKU count per call. Its established prescriber trust and essential-medicine status keep demand steady across the whole distribution chain.

Why Choose Cafoli Lifecare

Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.

References

1. MedlinePlus: Ciprofloxacin
2. PubChem: Ciprofloxacin
3. WHO Model List of Essential Medicines